US EditionNordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch - Pharmafile
International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) mark approval. This will allow the company to introduce the product across European markets within a few months and expand its global footprint. Lacrifill is a novel treatment which keeps eyes bathed in their own […] The post Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for Eu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage